Stock Rise | ABUS Message Board Posts

Arbutus Biopharma

  ABUS website

ABUS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34741 of 34756  at  12/5/2019 3:23:47 AM  by

Biogiek


 In response to msg 34740 by  evernewbliss
view thread

Re: Stock Rise

I find it hard to believe that Vir would be interested in 729 given that they already have an RNAi asset that is on par with Arrowhead's; the other compounds of ABUS are simply too early in development to be immediately ready for combo trials.

On the other hand, there are many Big Pharma companies (and I include Gilead here) that do not have exposure to HBV knockdown while it is becoming very clear by the data that RNAi is THE approach that is bringing the space a significant step forward towards functional cures. Nobody with HBV ambitions can afford to be left out here, and therein lies the value of ABUS IMO.

Glad that ABUS is picking up speed now. I expect momentum to continue as we have seemingly surmounted tax loss selling and there is so much catching up to do.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 4     Views: 233
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
34742 Re: Stock Rise evernewbliss 0 12/8/2019 2:34:28 PM






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...